News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 723 results

Lundbeck loses €150m pay-for-delay appeal

EU30-03-2021Alex Baldwin

Lundbeck has lost an appeal to the Court of Justice of the European Union (CJEU) to waive €150 million ($176 million) in fines levied against itself and a group of five generics manufacturers over ‘pay-for-delay’ deals for its antidepressant generics.

UK implored to back COVID-19 IP waiver at WTO

11-03-2021Muireann Bolger

The UK has been urged to back a proposed IP waiver related to COVID-19 treatments before the World Trade Organisation by business leaders, academics, economists and trade unions.

Five minutes with… Penny Gilbert

UK09-03-2021

The fallout from the landmark Regeneron v Kymab is still being weighed by the UK life sciences community.

AstraZeneca to buy Alexion for $39bn

UK, US14-12-2020Sarah Morgan

AstraZeneca has announced it will acquire Boston-based biopharmaceutical company Alexion Pharmaceuticals, in what is potentially the biggest life sciences deal of this year. 

Danish university sues Creative Biolabs over ‘antibody pirating’

Denmark, US09-12-2020Sarah Morgan

The University of Southern Denmark has accused biotech Creative Biolabs of infringing its patent-protected monoclonal antibody, HG-HYB 7-5. 

MSF urges EU to rid market of ‘avoidable suffering’ from SPCs

30-11-2020Rory O'Neill

Médecins Sans Frontières has warned that the European Commission’s commitment to the supplementary protection certificate system risks undermining its promise to improve drug accessibility.

EC fines Teva €60.5m over pay-for-delay deal

EU27-11-2020Sarah Morgan

The European Commission has fined Teva and its subsidiary Cephalon €60.5 million for agreeing to delay a cheaper generic version of sleep disorder drug modafinil.

Emer Cooke becomes first woman to lead EMA

Netherlands18-11-2020

The first woman to act as executive director of the European Medicines Agency (EMA) has officially started in the role.

UKIPO rejects BASF’s agri-chemical trademark opposition

EU17-11-2020

German chemicals company BASF has failed to persuade the UK Intellectual Property Office that an applied-for trademark to cover agricultural chemicals is confusingly similar to its own existing trademark.

EC signs contract with Pfizer to access watershed vaccine

EU12-11-2020Muireann Bolger

The European Commission has approved a fourth contract with pharmaceutical companies Pfizer and BioNTech, following their revelation that they had developed a vaccine that could potentially prevent more than 90% of people from becoming infected by COVID-19.

Showing 1 to 10 of 723 results

LSIPR